History favours originators in ECJ parallel trade case
This article was originally published in Scrip
Executive Summary
In cinematic terms tomorrow’s expected European Court of Justice ruling on dual pricing systems for medicines in the EU is nothing short of a cliff-hanger. The scene has aptly been set by two forays into the specifics of the case, first by the Court of First Instance and then by Advocate General Trstenjak.